PT-010 - WEIGHT-BASED DOSING IS NOT NEEDED FOR RIFAMPICIN FOR PATIENTS WITH TUBERCULOSIS (TB): PK EVIDENCE FROM TBTC STUDY S31/A5349 (STUDY S31).

H. Ngo¹, N. Zhang¹, V. Chang¹, W. Whitworth², K. Bryant², M. Weiner³, K. Dooley⁴, M. Engle³, S. Dorman⁵, P. Nahid¹, S. Swindells⁶, R. Chaisson⁴, P. Nsubuga⁷, M. Lourens⁸, R. Dawson⁹, R. Savic¹; ¹University of California San Francisco, San Francisco, CA, USA, ²Centers for Disease Control and Prevention, Atlanta, GA, USA, ³University of Texas Health Science Center at San Antonio, San Antonio, TX, USA, ⁴Johns Hopkins Medicine, Baltimore, MD, USA, ⁵Medical University of South Carolina, Charleston, SC, USA, ⁶University of Nebraska, Omaha, NE, USA, ⁷Mulago Hospital and the Makerere University School of Medicine, Kampala, Uganda, ⁸Task Applied Science, Western Cape, South Africa, ⁹University of Cape Town, Cape Town, South Africa.